44
Participants
Start Date
April 30, 2010
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
Victoza®
Patients taking Metformin at individual dose and Liraglutide 0.6 mg once daily for the 1st week, 1.2 mg daily for another 5 weeks, 1.8 mg daily for another 6 weeks. When arrived at the dosage of 1.8 mg daily and the dose is not tolerated by the patient, the dose of Liraglutide can be decreased.Liraglutide is injected in the subcutaneous tissue once daily
IKFE Institute for Clinical Research and Development, Mainz
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
IKFE Institute for Clinical Research and Development
OTHER
ikfe-CRO GmbH
INDUSTRY